Fig. 1From: An open-label clinical trial to investigate the efficacy and safety of corifollitropin alfa combined with hCG in adult men with hypogonadotropic hypogonadismMean (±SD) testicular volume at each study visit from pretreatment baseline to Week 52 of the combined treatment phaseBack to article page